Xtant Medical Holdings, Inc.XTNTNYSE
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+25.1%
5Y CAGR+21.7%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+25.1%/yr
vs -2.6%/yr prior
5Y CAGR
+21.7%/yr
Recent acceleration
Acceleration
+27.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
5 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$50.54M+3.0%
2024$49.05M+36.9%
2023$35.84M+38.7%
2022$25.83M+13.4%
2021$22.77M+20.2%
2020$18.95M-14.5%
2019$22.17M-22.8%
2018$28.72M-11.7%
2017$32.51M+17.3%
2016$27.71M-